We report on an exceedingly rare case of cutaneous and uterine leiomyomatosis in a 58-year-old Caucasian woman associated with ovarian cystadenoma and complete deletion of the fumarate hydratase gene. All patients and their family members with verified mutation have to be regularly screened for associated neoplasms, in particular papillary renal cell carcinoma (HLRCC, hereditary leiomyomatosis and renal cell cancer).
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Case report
We report on a 58-year-old Caucasian woman that was However, some plump cells were seen and interpreted as a clue to ancient changes (C, HE 400x). thus, a reliable statement about a given episodic versus familiar disease can not be given.
Fumarate hydratase is a constituent of the citric acid cycle and usually catalyzes the hydratation of fumarate to L-malate. However, the corresponding gene might be of additional impact as a tumor suppressor gene.
Leiomyomatosis cutis et uteri was first described in 1954
by Blum and Jean [1] . However, the eponymical denomination as Reed's syndrome was based on a corresponding case report published in 1973 [2] . The cutaneous lesions usually appear during adolescence, predominantly affecting the trunk and extremities in an agminated pattern [3] . A subset of patients is at relevant risk of early development of asso- Among the reported, although experimental, treatment options of the cutaneous leiomyomas are excision or ablation by laser, but also analgetic approaches using Botox, nifedipine, nitroglycerine, phenoxybenzamine, gabapentin, doxazosin or local anaesthetics [5] .
